ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Sanofi

Sanofi (SANF)

0.00
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

SANF Latest News

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma New Sarclisa subcutaneous formulation met co-primary endpoints in the...

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple La nouvelle...

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins pneumococciques conjugués

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins...

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Sanofi initiates phase 3 program for...

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors Jean-Paul Kress to join Sanofi's Board of Directors Paris, December 19, 2024. Sanofi's Board of Directors is pleased to...

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Paris, le 19 décembre 2024. Le Conseil...

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Duvakitug positive phase 2b results demonstrate best-in-class...

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de...

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire »

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire » Mise en ligne du document « Q4 2024 Aide-mémoire » Paris, France, le 17 Décembre 2024. Sanofi annonce la mise en ligne...

Press Release: Availability of the Q4 2024 Aide-mémoire

Press Release: Availability of the Q4 2024 Aide-mémoire Availability of the Q4 2024 Aide-mémoire Paris, France – December 17, 2024. Sanofi announced today that its Q4 2024 Aide-mémoire is...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

SANF - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?
The current share price of Sanofi is 0.00 €
What is the 1 year trading range for Sanofi share price?
Sanofi has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WERFOLaboratorio Farmaceutico Erfo SPA
0.097 €
(29.33%)
500
BESBestbe Holding
0.718 €
(19.67%)
73.76k
FREFrendy Energy Spa
0.282 €
(12.80%)
992.52k
1WBAWalgreens Boots Alliance Inc
9.949 €
(11.64%)
506
SIAVSiav Spa
2.20 €
(10.00%)
15.5k
WSBCCSicily by Car SpA
0.0289 €
(-27.75%)
12.69k
1UAAUnder Armour Inc
7.681 €
(-18.36%)
15
WTFINTrevi Finanziaria Industriale Spa
0.611 €
(-12.84%)
813
ELBEdgelab
6.58 €
(-9.25%)
30k
EGBEGlobe
0.945 €
(-9.13%)
27k
TITTelecom Italia SpA
0.2571 €
(-0.73%)
112.68M
ISPIntesa Sanpaolo Spa
4.01 €
(0.51%)
32.56M
SPMSaipem Spa
2.781 €
(0.98%)
17.11M
TITRTelecom Italia
0.2972 €
(-0.40%)
9.76M
BMPSBanca Monte Dei Paschi Di Siena Spa
6.982 €
(-0.80%)
9.56M

Discussion

View Full Feed
tw0122 tw0122 2 minutes ago
Gene editing news $5 to $7s next 
DTIL
Konaploinks Konaploinks 3 minutes ago
Common Peter! Do the cleanup on isle 4. Say something about Jensen remark. Damn. The mkt could care less about 5 years away. Address now!
IONQ
Ranb2khz Ranb2khz 3 minutes ago
See Me Through It – Brandon Heath (Lyrics Video)

[yt]Ffsy9nUIP1Y[/yt]

https://www.youtube.com/watch?v=Ffsy9nUIP1Y






linkvest linkvest 4 minutes ago
Its funny how there are slugs out there that actually think what they say will change what people think of a stock without facts or made up BS fake facts. They will tell you chit that doesn't even make sense and basically just lies. Will bash a stock and swear they own the stock that they are bashi
CEOS
Nogobeaver Nogobeaver 4 minutes ago
SGTM is not alone in this space. Enzyme treatment of organic materials. This process was discovered by German sciencest in the 1930s

REX-BACK- T
COMPOST ACCELERATOR | FMD-150 COMPOST ACTIVATOR
Recycle organic waste into nutrient rich compost with our FMD-150 compost act
SGTM
Iggy_Bot Iggy_Bot 4 minutes ago
People of California want money for their losses, go after the environmental groups and all the global scamming
liars
JCESOSA JCESOSA 4 minutes ago
Sit tight! News coming really soon! 
ASII
jimr1717 jimr1717 5 minutes ago
Absolutely! There is no reason to sell anything.
Just produce Fake it press releases, print shares, Reverse Split the stock and repeat.
For an even better effect hire a pink sheet stock pumper, gift shares to the employees and you have completed your cess pool.
SINT
RIGATONI RIGATONI 5 minutes ago
$3.46 lovely...

https://www.globenewswire.com/news-release/2025/01/10/3007606/0/en/Jeffs-Brands-Presents-Estimated-Year-over-Year-Growth-Targets-20-million-Revenue-in-2025-Anticipates-over-120-Revenue-Growth-since-its-IPO-in-2022.html


~Rig
Clark6290 Clark6290 5 minutes ago
Along4zride, what are your thoughts about the commons going into the weekend? Should we sell and not trust suit wearing, slick talking, car salesman Hedge fund manager.

We all rely on your experience and expertise.
FNMA
tedpeele tedpeele 5 minutes ago
anyone wanting to get out should consider placing an extended market (pre-market) order at a limit price. I just got out at 2.06 the few shares I had
LWLG
Rocking Jack Rocking Jack 6 minutes ago
Moving away, Marco, from the modulator business is probably the reason that Lebby was let go. He was probably against such a move. On the other hand, competition fears may have bin the reason for the delay in deal making, as you said it, and I agree. At least at the beginning, it probably better for
LWLG
meixatech meixatech 7 minutes ago
I might have posted this before... but still intriguing!

Acute ampakine treatment ameliorates age-related deficits in long-term potentiation –

Daniel P. Radin, Sheng Zhong, Richard Purcell, Arnold Lippa

Doi : 10.1016/j.biopha.2016.10.016 03/01/17
RSPI
Paulie Pennies Paulie Pennies 7 minutes ago
$ASII Think about it ... it's no accident that Secretary of State OTC markets have not been updated and GlobeTopper does not tweet anything the reverse merger will most likely be with FONTALK that's why I'm also looking for change of control filings.😎
ASII
glenn1919 glenn1919 7 minutes ago
MVST................................https://stockcharts.com/h-sc/ui?s=MVST&p=W&b=5&g=0&id=p86431144783
MVST
Monksdream Monksdream 8 minutes ago
DTIL there it goes
DTIL
Huggy Bear Huggy Bear 8 minutes ago
A few years? You've been pumping here for 12 years.

That's a few years now?
IFUS
034runner 034runner 9 minutes ago
Nice PM action
TNXP
Invest-in-America Invest-in-America 9 minutes ago
VMAR: Indeed!!! (@CGBS, noted.)
CGBS VMAR
Budots Budots 10 minutes ago
$XONI Xtreme One Entertainment began producing premier professional MMA events under its new team and investor community in 2024 and our fight card is full for the balance of the year and into 2025. In addition, new and exciting Xtreme live events – spanning combat sports, watersports and more – are
XONI
Budots Budots 10 minutes ago
$XONI The XFC has been in existence for nearly two decades and owns an extensive back catalog spanning thousands of hours of fights across the globe featuring some of MMA’s top fighters. This is the result of our often admired, but never duplicated focus on discovering talent and unlocking the poten
XONI
(SHUNNED) (SHUNNED) 10 minutes ago
Luca mining  ( lucmf )Monster in the making ! 
LUCMF
Thomas@yahoo Thomas@yahoo 10 minutes ago
DoorDash Will NOW Deliver Hemp CBD And THC Products In Response To ‘Growing Demand’ To Help Customers ‘Unwind And Recharge’
https://www.marijuanamoment.net/doordash-will-now-deliver-hemp-cbd-and-thc-products-in-response-to-growing-demand-to-help-customers-unwind-and-recharge/
CVSI
TheRealMrPirate TheRealMrPirate 11 minutes ago
You're welcome 👍️

Your Recent History

Delayed Upgrade Clock